Effect of addition of ivabradine to beta-blockers during cardiac rehabilitation in patients with recent coronary artery bypass

Trial Profile

Effect of addition of ivabradine to beta-blockers during cardiac rehabilitation in patients with recent coronary artery bypass

Completed
Phase of Trial: Phase II

Latest Information Update: 01 Nov 2015

At a glance

  • Drugs Ivabradine (Primary) ; Bisoprolol
  • Indications Coronary artery disease
  • Focus Therapeutic Use
  • Most Recent Events

    • 14 May 2014 New trial record
    • 31 Mar 2014 Results presented at the 63rd Annual Scientific Session of the American College of Cardiology.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top